Ontology highlight
ABSTRACT: Background
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, life-threatening terminal-complement-mediated disease resulting in intravascular hemolysis and thrombosis with significant morbidity and premature mortality. There exists no disease-specific quality-of-life (QOL) measure for PNH. Its QOL effects resemble those of hematologic cancers, which supports the use of cancer-specific QOL measures in PNH clinical trials. The European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 has published norms for many European and North American countries, but not for Asian countries. We investigated differences by Asian ethnicity in scores and item function on the EORTC QLQ-C30.Methods
This secondary analysis focused on two non-inferiority PNH trials (301 and 3
SUBMITTER: Schwartz CE
PROVIDER: S-EPMC8477512 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature